Bivamelagon reduced BMI by 9.3% at 600mg vs. 2.2% BMI increase on placebo in acquired hypothalamic obesity patients. Hunger ...

To improve access to care, many professional organizations have advocated for classifying obesity as a disease. However, the ...

About 1 in 5 classified as overweight based on BMI alone considered to have obesity according to European society definition.

Obesity in itself is not a contraindication to radical prostatectomy, but it remains a risk factor for poor overall survival. Although obesity increases the technical complexity of radical ...

Understanding the link between obesity, fatty liver disease and kidney stones provides a new perspective on prevention and ...

Obesity and heart failure often go together, making treatment more complicated. Now, health experts have released new ...

Bivamelagon achieved BMI reductions in patients with acquired hypothalamic obesity of -9.3% and -7.7% in 600mg and 400mg cohorts, respectively, at 14 weeks -- -- Post-hoc analysis showed BMI reduction ...

This precision in risk prediction allows for targeted interventions, potentially reducing unnecessary treatments and improving clinical outcomes.

Zuellig Pharma, a leading healthcare solutions provider in Asia, is organizing the "Obesity is a Disease" seminar as part of ...

When a team of scientists led by a Washington State University researcher examined the way that more than 9,400 children grew ...